Safety Issues
230
19
27
129
Key Insights
Highlights
Success Rate
98% trial completion (above average)
Published Results
17 trials with published results (7%)
Research Maturity
129 completed trials (56% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
1.3%
3 terminated out of 230 trials
97.7%
+11.2% vs benchmark
8%
19 trials in Phase 3/4
13%
17 of 129 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 129 completed trials
Clinical Trials (230)
Tenofovir Alafenamide Switching Therapy in Kidney or Liver Transplant Recipients With Chronic HBV Infection
A Phase 1 Study of the Safety and Tolerability of ICM20 in Adults
PK, Safety Study of 90-Day Use of Vaginal Rings Containing Dapivirine and Levonorgestrel
Pediatric Trauma Centers RE-AIM at Gun Safety
Adult Trauma Centers RE-AIM at Gun Safety
A Phase 1 Study to Evaluate the Safety/Tolerability, PK/PD of RG002C0106 Injection in Healthy Adults
Safety, Tolerability, PK and PD of SSS55 in Healthy Subjects
Safety of Cell-free Adipose Tissue Product in Healthy Volunteers
Real World Safety & Efficacy Experience of Empagliflozin With or Without Metformin in T2DM Patients - EASE Study
Safety of Ibuprofen After Major Orthopaedic Surgeries
E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults
Aerosolization During Upper Endoscopy
BeSMART Secure Storage Counseling in the Inpatient Setting
Effect of Lean Leadership Training Program on Head Nurses' Lean Performance and Staff Nurses' Workplace Safety at Mansoura Children Hospital
Phase1/2a Study for IPG7236 in Patients With Advanced Solid Tumors
The Safety and Efficiency of Endovascular Treatment of Acute or Subacute Thromboembolic Occlusions of Lower Extremity.
Safety and PK Multi-dose Study of TAF/EVG Vaginal Insert
Rectal Insert TAF/EVG Pre-Exposure Prophylaxis (RITE PrEP) Study
I Can sEe Left Atrial Appendage (ICELAA) Clinical Study
Effectiveness & Safety of Ovine Enoxaparin Sodium to Originator Enoxaparin in Non-ST-Segment Elevation ACS Patients